id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2020-0006-0007,DEA,DEA-2020-0006,Schedules of Controlled Substances: Placement of Cenobamate in Schedule V,Rule,,2020-08-20T04:00:00Z,2020,8,2020-08-20T04:00:00Z,,2020-08-21T18:10:51Z,2020-17357,0,0,0900006484813f86
DEA-2020-0006-0003,DEA,DEA-2020-0006,ASH Letter to Dhillon_01.15.2020,Supporting & Related Material,,2020-03-10T04:00:00Z,2020,3,,,2020-03-10T18:47:09Z,,0,0,0900006484426797
DEA-2020-0006-0002,DEA,DEA-2020-0006,8 Factor Cenobamate DEA March 2020 FINAL,Supporting & Related Material,,2020-03-10T04:00:00Z,2020,3,,,2020-03-11T12:53:52Z,,0,0,0900006484420e81
DEA-2020-0006-0001,DEA,DEA-2020-0006,Schedules of Controlled Substances: Placement of Cenobamate in Schedule V,Rule,,2020-03-10T04:00:00Z,2020,3,2020-03-10T04:00:00Z,2020-04-10T03:59:59Z,2020-04-10T01:03:34Z,2020-04963,0,0,090000648441faec
DEA-2020-0006-0004,DEA,DEA-2020-0006,HHS Letter to Dhillon_12.3.19,Supporting & Related Material,,2020-03-10T04:00:00Z,2020,3,,,2020-03-10T18:47:19Z,,0,0,09000064844274be